Voices & Stories

Who's actually talking about this — publicly.

Curated public commentary from athletes, physicians, podcasters, and founders. Not endorsements — signal. Each entry links to a public source so you can read the original context yourself.

BPC-157 / TB-500

Joe Rogan

Podcaster, comedian

Has spoken repeatedly on his podcast about using BPC-157 and TB-500 to recover from long-standing joint and tendon damage from martial arts.

Source: The Joe Rogan Experience

NAD+ pathway

Peter Attia, MD

Longevity physician

Discusses NAD+ precursors and the sirtuin pathway in the broader context of aging biology — a common reference point for the longevity crowd.

Source: The Drive podcast

Sermorelin / GHRH analogs

Andrew Huberman, PhD

Neuroscientist, Stanford

Has covered GHRH-analog peptides and sleep/GH pulses on Huberman Lab, framing them as a lever for recovery and sleep architecture.

Source: Huberman Lab

NAD+

Bryan Johnson

Founder, Blueprint

Openly documents his Blueprint protocol, which has publicly included NAD+ pathway support as part of his aging-reversal experiments.

Source: Blueprint

Semaglutide / Tirzepatide / Retatrutide

GLP-1 mainstream moment

Cultural conversation

GLP-1 agonists are the most talked-about compound class of the decade — reshaping conversations about metabolism, food noise, and body composition across Hollywood, tech, and mainstream media.

Source: General reporting

BPC-157, TB-500

Pro athletes & Olympians

Anecdotal reporting

Widely reported in sports-medicine coverage as a go-to for tendon and ligament recovery, though most governing bodies prohibit in-competition use.

Source: USADA / WADA prohibited list

Retatrutide

Terry Dubrow, MD

Plastic surgeon, TV personality

Has publicly discussed being an early adopter of next-gen GLP-1/GIP/glucagon triple-agonists like retatrutide, framing them as the likely successor to semaglutide and tirzepatide for weight loss and metabolic health.

Source: Public interviews & podcast appearances

Semaglutide (Wegovy)

Elon Musk

CEO, Tesla & SpaceX

Publicly credited Wegovy — a semaglutide GLP-1 — on X for his weight loss, one of the highest-profile personal disclosures that pulled the drug class into mainstream tech conversation.

Source: Elon Musk on X

GLP-1 class

Oprah Winfrey

Media

Openly discussed using a GLP-1 weight-management medication in a 2023 People cover interview and her ABC special 'Shame, Blame and the Weight Loss Revolution,' reframing the drugs as a legitimate medical tool.

Source: People — Oprah interview

NAD+

Mel Gibson

Actor, director

Discussed NAD+ IV therapy on The Joe Rogan Experience in the context of his father's late-life recovery — a moment widely credited with pushing NAD+ into mainstream longevity conversation.

Source: Joe Rogan Experience #1793

NAD+

Tony Robbins

Performance coach, author

Long-time public advocate of NAD+ IV protocols; covers the mitochondrial and longevity case for NAD+ at length in his 2022 book 'Life Force.'

Source: Life Force (Tony Robbins)

NAD+ & peptide protocols

Gary Brecka

Human biologist, podcaster

Peptides and NAD+ are signature topics on The Ultimate Human podcast, where he walks through protocols used by athletes, executives, and public figures he works with.

Source: The Ultimate Human Podcast

BPC-157 / TB-500 / NAD+

Dana White

UFC president

Publicly credited a peptide and NAD+ protocol — programmed with Gary Brecka — for a dramatic 2022 health turnaround, from body composition to sleep and inflammation.

Source: Ultimate Human interview

BPC-157 / TB-500 / GHK-Cu

Ben Greenfield

Biohacker, author

One of the most detailed public writers on peptide stacks — covers BPC-157 and TB-500 for tissue repair and GHK-Cu for skin, hair, and recovery across his blog and podcast.

Source: Ben Greenfield Life

GHK-Cu / NAD+

Dave Asprey

Founder, Bulletproof

Longtime public advocate for copper peptides (both topical and injectable) and NAD+ pathway support as core levers in his longevity and 'Smarter Not Harder' framework.

Source: Dave Asprey blog

BPC-157

Aubrey Marcus

Founder, Onnit

Has openly discussed BPC-157 on the Aubrey Marcus Podcast for gut lining and joint recovery, framing it as one of his most-used tools during heavy training blocks.

Source: Aubrey Marcus Podcast

Success Stories

Have a story to share?

Real-world experiences — dosing, timing, side effects, results — are some of the most useful things a beginner can read. If you've run a protocol and want to share what happened, we're collecting stories to publish anonymously.

Share your story →

Educational content only — not medical advice. See the basics before starting anything.